Fig. 3From: EGFR T790M detection and osimertinib treatment response evaluation by liquid biopsy in lung adenocarcinoma patients with acquired resistance to first generation EGFR tyrosine kinase inhibitorsctDNA T790 M quantification by ddPCR before and after osimertinib treatment. PD, Progressive Disease; PR, Partial Response; SD, Stable DiseaseBack to article page